SARS-CoV-2 Archives - Page 8 of 11 - Erwotex.net

Researchers develop protocols for rapid serological surveys of SARS-CoV-2 infection

15/02/2021 antibody, Biobanking, coronavirus, Coronavirus Disease COVID-19, cough, Diagnostic, epidemiology, pandemic, Personal Protective Equipment, PPE, Public Health, research, respiratory, Sars, SARS-CoV-2, Serology, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome

The rapid onset and growth of the coronavirus disease 2019 (COVID-19) pandemic, caused by the severe acute respiratory syndrome coronavirus

SARS-CoV-2's resistance to remdesivir in vitro

15/02/2021 Amino Acid, anti-inflammatory, Antiviral Drug, Cell, coronavirus, Coronavirus Disease COVID-19, dexamethasone, drugs, genome, Glucocorticoid, in vitro, Isoleucine, Mortality, mutation, Nucleoside, oxygen, pandemic, Protein, remdesivir, research, respiratory, RNA, Sars, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, syndrome, therapeutics, virus

With over 108 million reported infections from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide, and nearly 2.4 million deaths,

New SARS-CoV-2 variant found in newborn child with seizures in the United States

12/02/2021 Amino Acid, children, coronavirus, Coronavirus Disease COVID-19, genome, hospital, Newborn, Protein, respiratory, Sars, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, virus

Researchers at a hospital in Washington D.C. found a new mutant strain of the virus in a neonatal patient with

Antibodies to common cold coronaviruses do not protect against SARS-CoV-2

10/02/2021 against, antibodies, cold, Common, coronaviruses, Do, not, protect, SARS-CoV-2, to

Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that

Pfizer-BioNTech COVID-19 vaccine effective against variants, study shows

10/02/2021 ACE2, Amino Acid, antibodies, antibody, coronavirus, Coronavirus Disease COVID-19, medicine, mutation, Protein, receptor, respiratory, Sars, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Spike Protein, syndrome, vaccine, virus

Researchers at NYU Grossman School of Medicine in New York have conducted a study demonstrating the effectiveness of the Pfizer-BioNtech

Retrained generic antibodies can recognize SARS-CoV-2

06/02/2021 antibodies, can, generic, recognize, Retrained, SARS-CoV-2

SARS-CoV-2, the new coronavirus behind the current pandemic, infects humans by binding its surface-exposed spike proteins to ACE2 receptors exposed

where to buy generic zma-power usa without prescription

02/02/2021 against, B1.1.7, be, BioNTech, effective, likely, of, Pfizer, SARS-CoV-2, strain, to, vaccine

The Pfizer BioNTech vaccine BNT162b2 is likely to be effective against the B1.1.7 variant of SARS-CoV-2, even though its efficacy

Breastfeeding and COVID-19

31/01/2021 breastfeeding, COVID-19, SARS-CoV-2

Since its identification in December of 2019, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to spread rampantly around

Viral Clades of SARS-CoV-2

31/01/2021 clade, clades, SARS-CoV-2

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), since its outbreak in December 2019 in Wuhan, Hubei province, China, has quickly

What is Acute Respiratory Distress Syndrome (ARDS)?

30/01/2021 Acute Respiratory Distress Syndrome, blood, breathing, children, coronavirus, cough, Diagnostic, Edema, fever, heart, Lungs, Mortality, muscle, oxygen, Pancreatitis, pneumonia, Pulmonary Edema, respiratory, SARS-CoV-2, Sepsis, Severe Burns, trauma

Skip to: What causes ARDS? How does ARDS form? Signs and symptoms of ARDS Related conditions Diagnostic tests for ARDS